Pfizer Inc. (NYSE:PFE) registered a 0.45% increase, still its new closing price is 14.28% up from the company’s 1 year high of 36.72.It posted -1.10% losses in previous 5 sessions and is now the subject of 11 analysts who together assign a hold rating on stock. 0 of Wall Street analysts have an underperform rating; the 0 sells versus 4 buy or better ratings. The 23 stock analysts following this company have an average price target at $37.52, with individual PT in the $30.00-$53.00 range. The shares moved at $31.42, implying that brokerage firms see shares gaining about 7.97% in twelve months time.
Pfizer Inc. (PFE) SEC Form 4 News
The stock is getting much attention these days as insiders are offloading shares while they posted a -3.26% fall year to date. A Executive Vice President at Pfizer Inc. (PFE) offloaded shares in a transaction closed on Wednesday November 09, 2016. MADDALUNA ANTHONY J sold 10,000 shares in the company at $33 each and collected $330,000 in proceeds. MADDALUNA ANTHONY J now owns 166,789 shares in the company after this transaction. A Group President in the company, BOURLA ALBERT, disclosed a transaction on Friday November 04, 2016 that ended up generating $552,001 from the sale of 18,390 shares at $30.05 per share.
Pfizer Inc. (NYSE:PFE) Upcoming Results on Tap
Pfizer Inc. will next provide financial results for the March 2017 quarter. Stock analysts expect it to report per-share earnings of $0.64 in that period. Sales during the quarter are predicted to arrive at $13.3 billion.
Earnings surprise history: Last quarter, the company posted approximately $13.05 billion in revenue and EPS of $0.61. The mean forecast was for $13.04 billion and $0.62 a share, respectively. One quarter earlier, revenue for the stock was at $13.15 billion, with earnings at $0.64/share.
Pfizer Inc. (PFE) Brokerage Update
Pfizer Inc. (PFE) is in Argus’s research list so their analyst rating change is noteworthy. These shares were downgraded to Hold from Buy by Argus, according to news reported on Wednesday November 02, 2016.Another important research note was issued by Jefferies on Thursday October 13, 2016.The firm downgraded PFE to Hold from Buy. Over the last six months and over the last three months, the shares of Pfizer Inc. (PFE), have changed -12.74% and -2.06%, respectively.
